重大事件即時報告 8-K 2026-06-18

報告日期：2026年6月17日

AI 繁中摘要

📄 **申報類型**：8-K（重大事件報告）  
📅 **報告日期**：2026年6月17日  

**事件重點** 🚨  
Clover Health Investments 公佈，美國醫療保險和醫療補助服務中心（CMS）已正式更新其Medicare Advantage合約的星級評分，並自願重新計算2027年品質獎金支付（QBP）評級，以配合早前法院裁決（Clover Insurance Co. v. HHS）。  

**關鍵數字** 🔢  
- PPO合約（H5141）**2026年星級評分**由**3.5星升至4.5星**，影響2027支付年度。  
- HMO合約（H8010）**2026年星級評分**由**4.0星升至4.5星**，同樣影響2027支付年度。  

**管理層展望** 💡  
公司並未在本次文件中發表額外展望，但星級評分顯著提升（尤其PPO合約從3.5跳升至4.5），將直接帶動2027年CMS的品質獎金支付金額，對營收構成正面影響。更高的星級亦代表護理質量獲監管機構認可，有助增強投資者對公司Medicare Advantage業務競爭力的信心。  

**對投資者的潛在影響** 📈  
- **收入面**：4.5星評分屬頂級梯隊，相關合約將獲更高品質加成，直接改善現金流及利潤率。  
- **市場競爭力**：評級提升可吸引更多受益人選用Clover計劃，擴大市場份額。  
- **風險提示**：仍需關注CMS未來對評分方法的潛在調整，以及合約續期的不確定性。  

**總結**：是次星級評分調升屬重大利好，尤其PPO合約跳升幅度顯著，預期將成為公司2027年財務表現的重要催化劑。投資者宜密切留意後續季度業績中來自CMS的付款變動。

展開英文正文

clov-20260617FALSE0001801170CLOVER HEALTH INVESTMENTS, CORP. /DE00018011702026-06-172026-06-17

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 17, 2026

CLOVER HEALTH INVESTMENTS, CORP.

(Exact name of Registrant as Specified in Its Charter)

Delaware
001-3925298-1515192
(State or Other Jurisdiction
(Commission File Number)(IRS Employer

of Incorporation)
Identification No.)

Address Not Applicable(1)
Address Not Applicable(1)

(Address of Principal Executive Offices)(Zip Code)

Not Applicable(1)
(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Trading

Title of each class
Symbol(s)
Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per shareCLOVThe NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

(1) We are a remote-first company. Accordingly, we do not maintain a headquarters. For purposes of compliance with applicable requirements of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, stockholder communications required to be sent to our principal executive offices may be directed to the email address: [email protected], or to our agent for service of process at The Corporation Trust Company, 1209 Orange Street, Wilmington, Delaware 19801.

Item 8.01. Other Events.
As previously disclosed, on June 9, 2026, the Centers for Medicare & Medicaid Services ("CMS") informed Clover Health Investments, Corp. (the "Company") that, consistent with a court judgment in Clover Insurance Co. V. HHS, Civ. A. No. 25-142 (S.D. Ga), CMS had recalculated the 2026 Star Rating for the Company's PPO Medicare Advantage contract, H5141, from 3.5 Stars to 4.5 Stars for payment year 2027.
On June 17, 2026, CMS issued updated guidance informing all Medicare Advantage Organizations that it was voluntarily recalculating the 2027 Quality Bonus Payment ratings for certain Medicare Advantage contracts as a result of the preceding decision. 
CMS’s guidance stated that MA organizations can view their recalculated 2027 QBP ratings in the Health Plan Management System (HPMS). HPMS displays the Company's PPO Medicare Advantage contract, H5141, rated at 4.5 Stars for payment year 2027, and also displays that the 2026 Star Rating for the Company's HMO Medicare Advantage contract, H8010, increased from 4.0 Stars to 4.5 Stars, which also impacts payment year 2027.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Clover Health Investments, Corp.

Date:June 18, 2026By:/s/ Clay Thornton
Name:Clay Thornton
Title:Interim Chief Financial Officer (Principal Financial Officer)